159 related articles for article (PubMed ID: 38353683)
1. Cost-effectiveness of a multidimensional post-discharge disease management program for heart failure patients-economic evaluation along a one-year observation period.
Egelseer-Bruendl T; Jahn B; Arvandi M; Puntscher S; Santamaria J; Brunelli L; Weissenegger K; Pfeifer B; Neururer S; Rissbacher C; Huber A; Fetz B; Kleinheinz C; Modre-Osprian R; Kreiner K; Siebert U; Poelzl G
Clin Res Cardiol; 2024 Feb; ():. PubMed ID: 38353683
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and effectiveness of a multidimensional post-discharge disease management programme for heart failure patients in clinical practice: the HerzMobil Tirol programme.
Poelzl G; Egelseer-Bruendl T; Pfeifer B; Modre-Osprian R; Welte S; Fetz B; Krestan S; Haselwanter B; Zaruba MM; Doerler J; Rissbacher C; Ammenwerth E; Bauer A
Clin Res Cardiol; 2022 Mar; 111(3):294-307. PubMed ID: 34269863
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results.
Bocchi EA; da Cruz FDD; BrandÃo SM; Issa V; Ayub-Ferreira SM; Brunner la Rocca HP; Wijk SS
J Card Fail; 2018 Oct; 24(10):627-637. PubMed ID: 29723595
[TBL] [Abstract][Full Text] [Related]
4. Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.
Bhatt AS; Vaduganathan M; Claggett BL; Fonarow GC; Packer M; Pfeffer MA; Shah SJ; Shen X; Cristino J; McMurray JJV; Solomon SD; Gaziano TA
JAMA Cardiol; 2023 Nov; 8(11):1041-1048. PubMed ID: 37755814
[TBL] [Abstract][Full Text] [Related]
5. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
Pandor A; Thokala P; Gomersall T; Baalbaki H; Stevens JW; Wang J; Wong R; Brennan A; Fitzgerald P
Health Technol Assess; 2013 Aug; 17(32):1-207, v-vi. PubMed ID: 23927840
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
9. Community-based care for the specialized management of heart failure: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Transitional Care Services After Hospitalization With Heart Failure.
Blum MR; Øien H; Carmichael HL; Heidenreich P; Owens DK; Goldhaber-Fiebert JD
Ann Intern Med; 2020 Feb; 172(4):248-257. PubMed ID: 31986526
[TBL] [Abstract][Full Text] [Related]
12. HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria.
Von der Heidt A; Ammenwerth E; Bauer K; Fetz B; Fluckinger T; Gassner A; Grander W; Gritsch W; Haffner I; Henle-Talirz G; Hoschek S; Huter S; Kastner P; Krestan S; Kufner P; Modre-Osprian R; Noebl J; Radi M; Raffeiner C; Welte S; Wiseman A; Poelzl G
Wien Klin Wochenschr; 2014 Nov; 126(21-22):734-41. PubMed ID: 25392254
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial.
Sydow H; Prescher S; Koehler F; Koehler K; Dorenkamp M; Spethmann S; Westerhoff B; Wagner CJ; Liersch S; Rebscher H; Wobbe-Ribinski S; Rindfleisch H; Müller-Riemenschneider F; Willich SN; Reinhold T
Clin Res Cardiol; 2022 Nov; 111(11):1231-1244. PubMed ID: 34894273
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
Sanders-van Wijk S; van Asselt AD; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Vuillomenet A; Peter M; Pfisterer ME; Brunner-La Rocca HP;
JACC Heart Fail; 2013 Feb; 1(1):64-71. PubMed ID: 24621800
[TBL] [Abstract][Full Text] [Related]
15. HerzMobil, an Integrated and Collaborative Telemonitoring-Based Disease Management Program for Patients With Heart Failure: A Feasibility Study Paving the Way to Routine Care.
Ammenwerth E; Modre-Osprian R; Fetz B; Gstrein S; Krestan S; Dörler J; Kastner P; Welte S; Rissbacher C; Pölzl G
JMIR Cardio; 2018 Apr; 2(1):e11. PubMed ID: 31758765
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a follow-up program for older patients with heart failure: a randomized controlled trial.
González-Guerrero JL; Hernández-Mocholi MA; Ribera-Casado JM; García-Mayolín N; Alonso-Fernández T; Gusi N
Eur Geriatr Med; 2018 Aug; 9(4):523-532. PubMed ID: 34674493
[TBL] [Abstract][Full Text] [Related]
17. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
18. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.
Chew DS; Li Y; Zeitouni M; Whellan DJ; Kitzman D; Mentz RJ; Duncan P; Pastva AM; Reeves GR; Nelson MB; Chen H; Reed SD
JAMA Cardiol; 2022 Feb; 7(2):140-148. PubMed ID: 34817542
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
